Login
Toggle navigation
Videos
Categories
Trending
Night of Sciences' at X-FAB Erfurt | Manfred Riemer, CEO, X Fab Silicon Foundries EVXFAB:PAR
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Manfred Riemer is the CEO of this renowned company
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Focuses on early-stage venture investing in mobile marketplaces social infrastructure and enterprise software|Chetan Puttaguntak,General Partner,Benchmark
00:10:00
TCW understands the complex investment needs of institutions and individuals. Through constantly changing financial markets, TCW prides itself on providing products and solutions designed to meet the investment objectives of our clients | Katie Koch,Presi
00:00:00
Christopher U. Missling Ph.D. , CEO, Anavex Life Sciences Corp
00:10:00
Invests in early-stage startups that are disrupting the consumer entertainment industry|Yasushi Komori,General Partner,GFR Fund
00:10:00
Lahontan Gold: Strategic Development and Expansion of the Santa Fe Project in Nevada
00:10:00
Unlocking Miracles in DC: Mark Batterson's Journey of Faith and Community Transformation | Mark Batterson, Bestselling Author and Pastor, National Community Church
00:10:00
Joachim Nielsen Discusses Proximar Seafood’s Strategic Move to Japan | Joachim Nielsen , CEO, Proximar Seafood AS.
00:10:00
Unlocking Potential: Royal Road Minerals' Path to Resource Expansion in Latin America
00:10:00
Philogen CEO Dario Neri Introduces the Company to the City | Dario Neri, CEO ,Philogen spa.
00:10:00
The Age of Equities May Be Over: Insights from Jonathan Ruffer
00:00:00
Pathways Course Director (Integrated Human Pathophysiology III) / Melanie Hoenig, MD
00:10:00
Todd River Resources' Q1 Update: Drilling, Surveying, and Upcoming Catalysts